Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Streetwise Reports
The Gold Report
The Energy Report
more_reports

Streetwise ReportsThe Life Sciences Report

  • Menu
  • Articles
    • Biotechnology / Pharmaceuticals
    • Cannabis
    • Healthcare Services
    • Life Sciences Tools & Diagnostics
    • Medical Devices
    • Nutraceuticals
    • Psychedelics
    • Regenerative Medicine

Featured news in The Life Sciences Report



ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
CORRECTION: ProMIS Neurosciences Announces First Quarter 2022 Results (5/13/2022)

view
 


Athersys Inc. (ATHX:NASDAQ)
Athersys to Participate in the H.C. Wainwright Global Investment Conference (5/13/2022)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Holds Annual and Special Meeting of Shareholders All Resolutions Approved (5/13/2022)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Announces First Quarter 2022 Results (5/13/2022)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal (5/12/2022)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CDK, CLBS, TWTR, VWTR (5/11/2022)

view
 


Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB)
Avivagen Announces Approval in China, the World's Largest Commercial Feed Production Market (5/12/2022)

view
  • Subscribe
  • About
  • Disclaimer
  • Contact
  • Sponsorship
  • Syndication
  • Careers
  • Policies
FacebookTwitterEmailRSS FeedPrint This

© 2022 Streetwise Reports. All rights reserved.

Streetwise Reports is registered with the U.S. Patent and Trademark Office.

Streetwise Reports